Intelligence · Clinical Development
Pipeline search results
Programs matching “asthma” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 226 pipeline programs matching "asthma" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
BP44551
Hoffmann-La Roche
Moderate to Severe Asthma
1 trial -
Briquilimab
Jasper Therapeutics
Allergic Asthma
1 trial -
CLI-01535AA7-04
Chiesi Farmaceutici S.p.A
Asthma and chronic obstructive pulmonary disease (COPD).
1 trial -
CLI-01535AA9-03
Chiesi Farmaceutici S.p.A
Asthma
1 trial -
CLI-05993BB1-01
Chiesi Farmaceutici S.p.A
Asthma
1 trial -
D6830C00004
AstraZeneca AB
Asthma
1 trial -
D8210C00006
AstraZeneca AB
Asthma
1 trial -
Fluticasone Propionate MDPI
Teva Pharma GmbH
Asthma
1 trial -
GB-0895 (SC)
Generate Biomedicines
Asthma
1 trial -
GB-0895-101
Generate Biomedicines
mild to moderate asthma, Chronic Obstructive Pulmonary Disease (COPD)
1 trial -
JSP-CP-012
Jasper Therapeutics
allergic asthma
1 trial -
LT-02-19
Laboratorios Tillomed Spain S.L.U
Chronic spontaneous urticaria, Allergic asthma, Chronic rhinosinusitis with nasal polyps
1 trial -
Litapiprant Tablet
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Asthma
1 trial -
MRx-4DP0004
4D Molecular Therapeutics
Asthma
1 trial -
Placebo
The First People's Hospital of Lianyungang
Asthma
1 trial -
REGN3500
Regeneron UK Limited
Asthma
1 trial -
REGN3500
Regeneron UK Limited
Asthma, Allergic
1 trial -
SAD18184/MAD18185
Sanofi-aventis Healthcare Pty Ltd
Asthma
1 trial -
Treatment A
Pfizer
Asthma
1 trial -
Treatment A: Fp MDPI
Teva Pharma GmbH
Asthma
1 trial -
Yiqi Wenyang Sanhan Formula Combined with Acupoint Application
Universal Integrated
Allergic Rhinitis With Asthma
1 trial -
219871
GlaxoSmithKline
severe asthma
1 trial -
Advair Diskus100/50 µg
Teva Pharma GmbH
Asthma
1 trial -
AirDuo Digihaler
Teva Pharma GmbH
Asthma
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.